148 related articles for article (PubMed ID: 38508608)
1. Cervical cancer in a transgender man: lessons learnt to improve care.
Barrison L; Hoskins E
BMJ Case Rep; 2024 Mar; 17(3):. PubMed ID: 38508608
[TBL] [Abstract][Full Text] [Related]
2. Cytomorphologic findings of cervical Pap smears from female-to-male transgender patients on testosterone therapy.
Williams MPA; Kukkar V; Stemmer MN; Khurana KK
Cancer Cytopathol; 2020 Jul; 128(7):491-498. PubMed ID: 32125771
[TBL] [Abstract][Full Text] [Related]
3. Characteristic findings of cervical Papanicolaou tests from transgender patients on androgen therapy: Challenges in detecting dysplasia.
Adkins BD; Barlow AB; Jack A; Schultenover SJ; Desouki MM; Coogan AC; Weiss VL
Cytopathology; 2018 Jun; 29(3):281-287. PubMed ID: 29488269
[TBL] [Abstract][Full Text] [Related]
4. Clinical history of female-to-male transgender patients is needed to avoid misinterpretation of cervical Papanicolaou tests.
Moatamed NA; Barco AD; Yang SE; Ying Y; Zhang S; Rodriguez EF
Cytopathology; 2023 Mar; 34(2):120-129. PubMed ID: 36522845
[TBL] [Abstract][Full Text] [Related]
5. Understanding Transgender Men's Experiences with and Preferences for Cervical Cancer Screening: A Rapid Assessment Survey.
Seay J; Ranck A; Weiss R; Salgado C; Fein L; Kobetz E
LGBT Health; 2017 Aug; 4(4):304-309. PubMed ID: 28422558
[TBL] [Abstract][Full Text] [Related]
6. Surgical management and gynecologic care of the transgender patient.
Schmidt M; Ditrio L; Shute B; Luciano D
Curr Opin Obstet Gynecol; 2019 Aug; 31(4):228-234. PubMed ID: 31045656
[TBL] [Abstract][Full Text] [Related]
7. A Literature Review of Cervical Cancer Screening in Transgender Men.
Gatos KC
Nurs Womens Health; 2018 Feb; 22(1):52-62. PubMed ID: 29433700
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer prevention in transgender men: a review.
Weyers S; Garland SM; Cruickshank M; Kyrgiou M; Arbyn M
BJOG; 2021 Apr; 128(5):822-826. PubMed ID: 32931650
[TBL] [Abstract][Full Text] [Related]
9. Cervical Cancer Screening with Human Papillomavirus Self-Sampling Among Transgender Men in El Salvador.
Maza M; Meléndez M; Herrera A; Hernández X; Rodríguez B; Soler M; Alfaro K; Masch R; Conzuelo-Rodríguez G; Obedin-Maliver J; Cremer M
LGBT Health; 2020; 7(4):174-181. PubMed ID: 32407149
[No Abstract] [Full Text] [Related]
10. Young Adult Patients with Testosterone Management Concerns after Gender-Affirming Hysterectomy and Bilateral Oophorectomy: A Case Series.
Barrera EP; Grimstad FW; Boskey ER
J Pediatr Adolesc Gynecol; 2023 Feb; 36(1):89-91. PubMed ID: 35850361
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Cervical Cancer Screen Results on Female-to-Male Transgender Patients With Female Patients.
Davis K; Kwon R; Graham A; White M; Maleki Z; Rodriguez E
Am J Clin Pathol; 2022 Apr; 157(4):540-545. PubMed ID: 34617991
[TBL] [Abstract][Full Text] [Related]
12. Female-to-male patients have high prevalence of unsatisfactory Paps compared to non-transgender females: implications for cervical cancer screening.
Peitzmeier SM; Reisner SL; Harigopal P; Potter J
J Gen Intern Med; 2014 May; 29(5):778-84. PubMed ID: 24424775
[TBL] [Abstract][Full Text] [Related]
13. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?
Subramaniam A; Fauci JM; Schneider KE; Whitworth JM; Erickson BK; Kim K; Huh WK
J Low Genit Tract Dis; 2011 Apr; 15(2):110-3. PubMed ID: 21263352
[TBL] [Abstract][Full Text] [Related]
14. Surface prostatic metaplasia, transitional cell metaplasia and superficial clusters of small basophilic cells in the uterine cervix: prevalence in gender-affirming hysterectomies and comparison with benign hysterectomies from cisgender women.
McMullen-Tabry ER; Sciallis AP; Skala SL
Histopathology; 2022 May; 80(6):946-953. PubMed ID: 34664289
[TBL] [Abstract][Full Text] [Related]
15. Perceptions of Transgender and Nonbinary Persons Toward Breast and Cervical Cancer Development, Screening, and Potential Impact on Gender-Affirming Hormone Therapy.
Roznovjak D; Petroll AE; Lakatos AEB; Narayan R; Cortina CS
JCO Oncol Pract; 2023 May; 19(5):e794-e800. PubMed ID: 36800556
[TBL] [Abstract][Full Text] [Related]
16. Attitudes of transgender men and non-binary people to cervical screening: a cross-sectional mixed-methods study in the UK.
Berner AM; Connolly DJ; Pinnell I; Wolton A; MacNaughton A; Challen C; Nambiar K; Bayliss J; Barrett J; Richards C
Br J Gen Pract; 2021 Aug; 71(709):e614-e625. PubMed ID: 34001539
[TBL] [Abstract][Full Text] [Related]
17. Cervical Papanicolaou tests in the female-to-male transgender population: should the adequacy criteria be revised in this population? An Institutional Experience.
Plummer RM; Kelting S; Madan R; O'Neil M; Dennis K; Fan F
J Am Soc Cytopathol; 2021; 10(3):255-260. PubMed ID: 33736951
[TBL] [Abstract][Full Text] [Related]
18. Bridging Barriers to Cervical Cancer Screening in Transgender Men: A Scoping Review.
Dhillon N; Oliffe JL; Kelly MT; Krist J
Am J Mens Health; 2020; 14(3):1557988320925691. PubMed ID: 32489142
[TBL] [Abstract][Full Text] [Related]
19. Recent Penile Sexual Contact Is Associated With an Increased Odds of High-Risk Cervical Human Papillomavirus Infection in Transgender Men.
Deutsch MB; Reisner SL; Peitzmeier S; Potter J; Pardee D; Hughto JMW
Sex Transm Dis; 2020 Jan; 47(1):48-53. PubMed ID: 31567654
[TBL] [Abstract][Full Text] [Related]
20. Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests.
McDowell M; Pardee DJ; Peitzmeier S; Reisner SL; Agénor M; Alizaga N; Bernstein I; Potter J
LGBT Health; 2017 Aug; 4(4):252-259. PubMed ID: 28665783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
